Nasdaq
CHRS
Coherus Oncology, Inc.
- Health Care
- Listed 2014
- 1 day
- −12.8%
- 1 month
- −24.3%
- 1 year
- +38.1%
$1.27 · Mkt cap $195M · P/E 0.88
At the 6 Aug 2026 close
Nasdaq
Coherus Oncology, Inc.
$1.27 · Mkt cap $195M · P/E 0.88
At the 6 Aug 2026 close
Coherus Oncology, Inc. trades under the ticker CHRS on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2014. Its market capitalisation is $195M. The last closing price was $1.27, on 6 Aug 2026. It trades at 0.88 times its last reported annual diluted earnings per share. Over the past year the share price is +38.1%, and −24.3% over the past month. Returns are price returns and exclude dividends.
This page exists because CHRS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.